Anthem Biosciences Ltd files quarterly financial results for period ended 30 June 2026
The company submitted its Q2 FY2026 results to the BSE on 21 July 2026, covering the quarter ended 30 June 2026.
What Anthem Biosciences announced
On 21 July 2026, Anthem Biosciences Ltd submitted a filing to the Bombay Stock Exchange (BSE) titled Financial Results for the quarter ended June 30, 2026. The filing satisfies the statutory requirement to disclose quarterly performance for the second quarter of its fiscal year 2026‑27.
"Financials Results for the quarter ended June 30, 2026" – BSE filing, 21 July 2026.
The announcement does not provide a narrative summary of the numbers; instead, it points investors to the accompanying PDF document for the detailed statement of profit and loss, balance sheet, and cash‑flow items.
Filing details
- Company: Anthem Biosciences Ltd
- BSE ticker: 544449 (no NSE ticker listed)
- Filing date: 21 July 2026 (11:17 UTC)
- Period covered: Quarter ended 30 June 2026
- Source URL: https://www.bseindia.com/xml-data/corpfiling/AttachLive/c93f3775-993c-4788-905c-dbe631194ac3.pdf
The PDF linked in the filing is expected to contain the full set of financial statements, notes, and management discussion. The brief description accompanying the filing on the BSE portal does not disclose any specific financial metrics such as revenue, net profit, or earnings per share.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Anthem Biosciences Ltd |
| BSE ticker | 544449 |
| Filing date | 21 July 2026 (11:17 UTC) |
| Reporting period | Quarter ended 30 June 2026 |
| Document link | BSE PDF (c93f3775‑…‑ac3.pdf) |
| Financial figures disclosed | Not provided in summary |
Why this matters for investors
The filing confirms that Anthem Biosciences is complying with Indian securities regulations by publishing its quarterly results within the prescribed timeline. While the summary does not reveal performance numbers, the existence of the filing assures shareholders that the company is maintaining transparency. Investors seeking quantitative insight must review the PDF to assess revenue trends, profitability, and cash‑flow health for the quarter.
Conclusion
Anthem Biosciences Ltd has formally filed its Q2 FY2026 financial results with the BSE on 21 July 2026, covering the quarter ended 30 June 2026. The brief filing notice does not disclose specific financial figures; interested parties should consult the linked PDF for the complete statements. No further corporate actions or disclosures were indicated in the filing.
Frequently asked questions
Related stocks
Source filing: view original